Clinical and Electrophysiological Heterogeneity in Adult Charcot-Marie-Tooth Disease
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nice
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 250 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults aged 18 years or older
- Diagnosis of peripheral sensory polyneuropathy
- Classification as length-dependent (LDN) or non-length-dependent (NLDN) based on clinical and electrophysiological findings
- Available nerve conduction study including sural and radial sensory nerve amplitudes allowing calculation of the SRAR
- Evaluated at the Peripheral Neuromuscular Rare Disease Reference Center, Nice University Hospital, between January 2013 and July 2026
Who cannot take part
- Missing or incomplete clinical or electrophysiological data preventing SRAR calculation
- Unclassifiable neuropathy phenotype
- Technical factors affecting the reliability of nerve conduction studies
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
CMT-PROFILE is a single-center, cross-sectional observational study involving adults with Charcot-Marie-Tooth disease (CMT). The study will investigate the association between clinical disease severity, measured using the CMT Examination Score version 2 (CMTES-v2), and motor electrophysiological parameters, including compound muscle action potential (CMAP) amplitudes and motor nerve conduction velocities. Secondary objectives include characterizing clinical-electrophysiological concordance, comparing functional capacity, muscle strength and mobility across concordance groups, and exploring demographic, clinical, biological and genetic factors associated with variability in disease expression. Approximately 250 patients are planned for inclusion. All assessments will be performed at a single reference time point (M0), with no longitudinal follow-up.
The group in the trial
- Adults with Charcot-Marie-Tooth Disease
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical and Electrophysiological Heterogeneity in Adult Charcot-Marie-Tooth Disease: An Observational Study of the Relationships Between CMTES-v2, Nerve Conduction Parameters, and Functional Capacity
- Record updated
- 16 November 2026